These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 17549355)

  • 21. [Drug concentration in axillary lymph nodes of patients with breast cancer after lymphatic chemotherapy].
    Chen JH; Yang YM; Li KZ; Ling R; Yao Q; Yang H
    Ai Zheng; 2005 Apr; 24(4):494-7. PubMed ID: 15820077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.
    Kristek J; Dmitrović B; Kurbel S; Sakić K; Krajinović Z; Blazicević V; Has B; Marjanović K
    Coll Antropol; 2007 Dec; 31(4):1043-7. PubMed ID: 18217456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
    Buchholz TA; Garg AK; Chakravarti N; Aggarwal BB; Esteva FJ; Kuerer HM; Singletary SE; Hortobagyi GN; Pusztai L; Cristofanilli M; Sahin AA
    Clin Cancer Res; 2005 Dec; 11(23):8398-402. PubMed ID: 16322301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil.
    Tahara M; Ochiai A; Fujimoto J; Boku N; Yasui W; Ohtsu A; Tahara E; Yoshida S
    Oncol Rep; 2004 Jan; 11(1):9-15. PubMed ID: 14654896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the apoptotic markers in normal breast epithelium, benign mammary dysplasia and in breast cancer.
    Koda M; Kanczuga-Koda L; Reszec J; Sulkowska M; Famulski W; Baltaziak M; Kisielewski W; Sulkowski S
    Folia Morphol (Warsz); 2004 Aug; 63(3):337-41. PubMed ID: 15478112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
    Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.
    Bottini A; Berruti A; Bersiga A; Brizzi MP; Allevi G; Bolsi G; Aguggini S; Brunelli A; Betri E; Generali D; Scaratti L; Bertoli G; Alquati P; Dogliotti L
    Clin Cancer Res; 2002 Jun; 8(6):1816-21. PubMed ID: 12060622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome.
    Iguchi C; Nio Y; Itakura M
    J Surg Oncol; 2003 Jun; 83(2):85-93. PubMed ID: 12772201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
    Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A
    Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
    Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
    BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer.
    Koda M; Sulkowski S; Kanczuga-Koda L; Surmacz E; Sulkowska M
    Oncol Rep; 2004 Apr; 11(4):753-9. PubMed ID: 15010868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.
    Olopade OI; Adeyanju MO; Safa AR; Hagos F; Mick R; Thompson CB; Recant WM
    Cancer J Sci Am; 1997; 3(4):230-7. PubMed ID: 9263629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive biological markers for response of invasive breast cancer to anthracycline/cyclophosphamide-based primary (radio-)chemotherapy.
    Prisack HB; Karreman C; Modlich O; Audretsch W; Danae M; Rezai M; Bojar H
    Anticancer Res; 2005; 25(6C):4615-21. PubMed ID: 16334152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer.
    Burcombe R; Wilson GD; Dowsett M; Khan I; Richman PI; Daley F; Detre S; Makris A
    Breast Cancer Res; 2006; 8(3):R31. PubMed ID: 16790076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Bcl-2 family proteins in psoriasis.
    Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V
    Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
    Sjöström J; Blomqvist C; von Boguslawski K; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Wist E; Valvere V; Takayama S; Reed JC; Saksela E
    Clin Cancer Res; 2002 Mar; 8(3):811-6. PubMed ID: 11895913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.